These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 19851773)

  • 21. [Persistent remission of Takayasu aortoarteritis induced by long-term treatment with infliximab and confirmed by repeat positron emission tomography].
    Krivosheev OG; Smitienko IO; Aslanidi IP; Mukhortova OV
    Ter Arkh; 2008; 80(10):90-3. PubMed ID: 19105425
    [No Abstract]   [Full Text] [Related]  

  • 22. Takayasu Arteritis in the pediatric population: a contemporary United States-based single center cohort.
    Szugye HS; Zeft AS; Spalding SJ
    Pediatr Rheumatol Online J; 2014; 12():21. PubMed ID: 24955077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Infliximab is effective for Takayasu arteritis refractory to glucocorticoid and methotrexate.
    Tanaka F; Kawakami A; Iwanaga N; Tamai M; Izumi Y; Aratake K; Arima K; Kamachi M; Nakamura H; Huang M; Ida H; Origuchi T; Eguchi K
    Intern Med; 2006; 45(5):313-6. PubMed ID: 16596001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful infliximab treatment in a patient with Takayasu arteritis associated with ulcerative colitis or migration does not override genetics.
    Gecse K; Ruzsa Z; Nagy F; Wittmann T; Molnár T
    Inflamm Bowel Dis; 2011 Jul; 17(7):E69-70. PubMed ID: 21538713
    [No Abstract]   [Full Text] [Related]  

  • 25. Efficacy and tolerance of infliximab in refractory Takayasu arteritis: French multicentre study.
    Mekinian A; Néel A; Sibilia J; Cohen P; Connault J; Lambert M; Federici L; Berthier S; Fiessinger JN; Godeau B; Marie I; Guillevin L; Hamidou M; Fain O;
    Rheumatology (Oxford); 2012 May; 51(5):882-6. PubMed ID: 22223706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-tumour necrosis factor therapy in patients with refractory Takayasu arteritis: long-term follow-up.
    Molloy ES; Langford CA; Clark TM; Gota CE; Hoffman GS
    Ann Rheum Dis; 2008 Nov; 67(11):1567-9. PubMed ID: 18677012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Takayasu's or tuberculous arteritis?
    Moura C; Aquino MA; Rocha Filho J; Santiago M
    BMJ Case Rep; 2015 Jun; 2015():. PubMed ID: 26106169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Takayasu arteritis: anti-TNF therapy in a Brazilian setting.
    Nunes G; Neves FS; Melo FM; de Castro GR; Zimmermann AF; Pereira IA
    Rev Bras Reumatol; 2010; 50(3):291-8. PubMed ID: 21125165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Refractory retinal vasculitis due to sarcoidosis successfully treated with infliximab.
    Cruz BA; Reis DD; Araujo CA;
    Rheumatol Int; 2007 Oct; 27(12):1181-3. PubMed ID: 17520259
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Profiles of serum cytokine levels in Takayasu arteritis patients: Potential utility as biomarkers for monitoring disease activity.
    Tamura N; Maejima Y; Tezuka D; Takamura C; Yoshikawa S; Ashikaga T; Hirao K; Isobe M
    J Cardiol; 2017 Sep; 70(3):278-285. PubMed ID: 27989502
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Two Takayasu arteritis patients successfully treated with infliximab: a potential disease-modifying agent?
    Della Rossa A; Tavoni A; Merlini G; Baldini C; Sebastiani M; Lombardi M; Neglia D; Bombardieri S
    Rheumatology (Oxford); 2005 Aug; 44(8):1074-5. PubMed ID: 15840604
    [No Abstract]   [Full Text] [Related]  

  • 32. Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trial.
    Hoffman GS; Cid MC; Rendt-Zagar KE; Merkel PA; Weyand CM; Stone JH; Salvarani C; Xu W; Visvanathan S; Rahman MU;
    Ann Intern Med; 2007 May; 146(9):621-30. PubMed ID: 17470830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Takayasu's arteritis occurring under TNF-α blockers: a new paradoxical effect?
    Souabni L; Ben Abdelghani K; Jradi S; Zakraoui L
    BMJ Case Rep; 2014 Nov; 2014():. PubMed ID: 25422327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retrospective analysis of children with uveitis treated with infliximab.
    Tugal-Tutkun I; Ayranci O; Kasapcopur O; Kir N
    J AAPOS; 2008 Dec; 12(6):611-3. PubMed ID: 18930672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Great Vessels of Children: Takayasu's Arteritis.
    de Ranieri D
    Pediatr Ann; 2015 Jun; 44(6):e148-52. PubMed ID: 26114370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel therapeutic strategies for large vessel vasculitis.
    Koening CL; Langford CA
    Rheum Dis Clin North Am; 2006 Feb; 32(1):173-86, xi. PubMed ID: 16504829
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Tocilizumab for refractory Takayasu arteritis with aortic aneurysm].
    Frikha F; Garbaa S; Bouattour Y; Snoussi M; Loukil H; Ben Salah R; Bahloul Z
    J Med Vasc; 2019 May; 44(3):237-239. PubMed ID: 31029281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tocilizumab for Treating Takayasu's Arteritis and Associated Stroke: A Case Series and Updated Review of the Literature.
    Osman M; Emery D; Yacyshyn E
    J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1291-8. PubMed ID: 25869777
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined immunosuppressive therapy including a TNF-alpha blocker induces remission in a difficult to treat patient with Takayasu arteriitis and coronary involvement.
    Mahlmann A; Pfluecke C; Ouda A; Simonis G; Weiss N; Kappert U
    Vasa; 2012 Nov; 41(6):451-7. PubMed ID: 23129041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation and therapy in four patients with Takayasu's arteritis.
    Conkar S; Mir S; Sözeri B; Bulut İK; Çınar C
    Saudi J Kidney Dis Transpl; 2016 Jan; 27(1):164-9. PubMed ID: 26787588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.